• Logo
  • SBMUJournals

Validation of SUSPEKT Score in Predicting One-month Mortality of Patients with Hemorrhagic Stroke; a Diagnostic Accuracy Study

Hamid Kariman, Hamidreza Hatamabadi, Majid Shojaee, Farhad Asarzadegan, Simin Saljughi




Introduction: Predicting the outcome of patients with intracranial hemorrhage (ICH) is the area of interest for in charge physicians as well as patients and their associates. This study aimed to evaluate the accuracy of SUSPEKT score in predicting one-month outcome of patients with hemorrhagic stroke.

Methods: This prospective cross sectional study was conducted on > 18 years old patients with non-traumatic supra-tentorial ICH admitted to emergency department, from February 2017 to January 2018. SUSPEKT score was measured for each patient and its screening performance characteristics in prediction of one-month mortality were calculated.

Results: 169 cases with the mean age of 63.09± 15.45 (21 – 96) years were studied (56.8% male). After one month follow up 47 (27.8%) cases had died, 30 (17.7%) cases were bed ridden, and 72 (42.6%) could walk without help or with a cane. Non-survived patients had significantly larger intra-ventricular hemorrhage (IVH) (p < 0.001) and hematoma (p < 0.001) volume, higher serum glucose (p < 0.001) and blood pressure (p = 0.028), higher frequency of IVH (p < 0.001), and higher WBC count (p = 0.037). Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of SUSPEKT score at the 65 cut point were 82.97% (95% CI: 68.65% – 91.86%), 74.59% (95% CI: 65.76% – 81.84%), 55.71% (95% CI: 43.38% – 67.40%), and 91.91% (95% CI: 84.23% – 96.16%), respectively.

Conclusion: Total accuracy of SUSPEKT score in predicting one-month mortality of non- traumatic ICH patients is in good range and it has 82% sensitivity and 92% NPV in this regard. It seems that we need further studies before applying the score in routine practice.


Intracranial hemorrhages; stroke; decision support techniques; prognosis; patient outcome assessment; mortality


Qureshi AI, Mohammad YM, Yahia AM, Suarez JI, Siddiqui AM, Kirmani JF, et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. Journal of intensive care medicine. 2005;20(1):34-42.

Steiner T, Al‐Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, et al. E uropean S troke O rganisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. International journal of stroke. 2014;9(7):840-55.

Sahni R, Weinberger J. Management of intracerebral hemorrhage. Vascular health and risk management. 2007;3(5):701-9.

Krishnamurthi RV, Moran AE, Forouzanfar MH, Bennett DA, Mensah GA, Lawes CM, et al. The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study. Global heart. 2014;9(1):101-6.

van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. The Lancet Neurology. 2010;9(2):167-76.

Ruiz-Sandoval JL, Chiquete E, Romero-Vargas S, Padilla-Martínez JJ, González-Cornejo S. Grading scale for prediction of outcome in primary intracerebral hemorrhages. Stroke. 2007;38(5):1641-4.

Ziai WC, Carhuapoma JR. Intracerebral Hemorrhage. Continuum: Lifelong Learning in Neurology. 2018;24(6):1603-22.

Sandeep YS, Guru MR, Jena RK, Kumar VAK, Agrawal A. Clinical study to assess the outcome in surgically managed patients of spontaneous intracerebral hemorrhage. International journal of critical illness and injury science. 2017;7(4):218.

Szepesi R, Széll IK, Hortobágyi T, Kardos L, Nagy K, Lánczi LI, et al. New prognostic score for the prediction of 30-day outcome in spontaneous supratentorial cerebral haemorrhage. BioMed research international. 2015;2015.

Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24(7):987-93.

Weimar C, Benemann J, Diener H. Development and validation of the Essen intracerebral haemorrhage score. Journal of Neurology, Neurosurgery & Psychiatry. 2006;77(5):601-5.

Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score. Stroke. 2001;32(4):891-7.

Tuhrim S, Dambrosia JM, Price TR, Mohr JP, Wolf PA, Hier DB, et al. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30‐day survival. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 1991;29(6):658-63.

Gomis M, Ois A, Rodriguez‐Campello A, Cuadrado‐Godia E, Jiménez‐Conde J, Subirana I, et al. Outcome of intracerebral haemorrhage patients pre‐treated with statins. European journal of neurology. 2010;17(3):443-8.

Gebel Jr JM, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke. 2002;33(11):2636-41.

Nilsson OG, Lindgren A, Brandt L, Säveland H. Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. Journal of neurosurgery. 2002;97(3):531-6.

Reinhard M, Neunhoeffer F, Gerds TA, Niesen W-D, Buttler K-J, Timmer J, et al. Secondary decline of cerebral autoregulation is associated with worse outcome after intracerebral hemorrhage. Intensive care medicine. 2010;36(2):264-71.

Tsikriki S, Karathanou A, Kokoris I, Topalis T, Voutsinas E, Antoniou A, et al. Prognostic factors of 30-days mortality in primary intracerebral hemorrhage. 2015;3(S1):A983.

Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. Journal of Neurology, Neurosurgery & Psychiatry. 2005;76(3):349-53.

Stead LG, Jain A, Bellolio MF, Odufuye A, Gilmore RM, Rabinstein A, et al. Emergency Department hyperglycemia as a predictor of early mortality and worse functional outcome after intracerebral hemorrhage. Neurocritical care. 2010;13(1):67-74.

Hemphill III JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032-60.

Tetri S, Juvela S, Saloheimo P, Pyhtinen J, Hillbom M. Hypertension and diabetes as predictors of early death after spontaneous intracerebral hemorrhage. Journal of neurosurgery. 2009;110(3):411-7.

Lee S-H, Kim B, Bae H-J, Lee J, Lee J, Park B-J, et al. Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study. Diabetologia. 2010;53(3):429-34.

Nisar T, Alchaki A, Hillen MJCn, neurosurgery. Validation of ICH score in a large urban population. 2018;174:36-9.

Tsikriki S, Karathanou A, Kokoris I, Topalis T, Voutsinas E, Antoniou A, et al. Prognostic factors of 30-days mortality in primary intracerebral hemorrhage. Intensive care medicine experimental. 2015;3(S1):A983.

Ueshima H, Reza Choudhury S, Okayama A, Hayakawa T, Kita Y, Kadowaki T, et al. Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke. 2004;35(8):1836-41.

Wong K. Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage: a prospective hospital-based study in Asia. Stroke. 1999;30(11):2326-30.

Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28(1):1-5.


  • There are currently no refbacks.